- Home
- CHRW vs PCVX Comparison
CHRW vs PCVX Comparison
Compare CHRW & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- PCVX
- Stock Information
- Founded
- CHRW 1905
- PCVX 2013
- Country
- CHRW United States
- PCVX United States
- Employees
- CHRW N/A
- PCVX N/A
- Industry
- CHRW Oil Refining/Marketing
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- CHRW Consumer Discretionary
- PCVX Health Care
- Exchange
- CHRW Nasdaq
- PCVX Nasdaq
- Market Cap
- CHRW 12.3B
- PCVX 9.4B
- IPO Year
- CHRW 1997
- PCVX 2020
- Fundamental
- Price
- CHRW $96.39
- PCVX $73.00
- Analyst Decision
- CHRW Buy
- PCVX Strong Buy
- Analyst Count
- CHRW 18
- PCVX 9
- Target Price
- CHRW $120.69
- PCVX $147.50
- AVG Volume (30 Days)
- CHRW 1.3M
- PCVX 1.2M
- Earning Date
- CHRW 04-30-2025
- PCVX 05-07-2025
- Dividend Yield
- CHRW 2.57%
- PCVX N/A
- EPS Growth
- CHRW 41.91
- PCVX N/A
- EPS
- CHRW 3.86
- PCVX N/A
- Revenue
- CHRW $17,724,956,000.00
- PCVX N/A
- Revenue This Year
- CHRW $2.25
- PCVX N/A
- Revenue Next Year
- CHRW $4.65
- PCVX N/A
- P/E Ratio
- CHRW $24.92
- PCVX N/A
- Revenue Growth
- CHRW 0.73
- PCVX N/A
- 52 Week Low
- CHRW $65.00
- PCVX $58.10
- 52 Week High
- CHRW $114.82
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- CHRW 42.97
- PCVX 44.93
- Support Level
- CHRW $95.08
- PCVX $67.23
- Resistance Level
- CHRW $105.27
- PCVX $76.38
- Average True Range (ATR)
- CHRW 2.77
- PCVX 4.21
- MACD
- CHRW -0.10
- PCVX 0.03
- Stochastic Oscillator
- CHRW 19.53
- PCVX 48.71
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.